These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 2808191)
1. Cytotoxicity and uptake of pefloxacin, ciprofloxacin, and ofloxacin in primary cultures of rat hepatocytes. Nordmann P; Pechinot A; Kazmierczak A J Antimicrob Chemother; 1989 Sep; 24(3):355-63. PubMed ID: 2808191 [TBL] [Abstract][Full Text] [Related]
2. Adverse testicular effects of some quinolone members in rats. Abd-Allah AR; Aly HA; Moustafa AM; Abdel-Aziz AA; Hamada FM Pharmacol Res; 2000 Feb; 41(2):211-9. PubMed ID: 10623489 [TBL] [Abstract][Full Text] [Related]
3. Study of potential in vitro and in vivo genotoxicity in hepatocytes of quinolone antibiotics. McQueen CA; Way BM; Queener SM; Schlüter G; Williams GM Toxicol Appl Pharmacol; 1991 Nov; 111(2):255-62. PubMed ID: 1957311 [TBL] [Abstract][Full Text] [Related]
4. Oral toxicity of pefloxacin, norfloxacin, ofloxacin and ciprofloxacin: comparison of biomechanical and histopathological effects on Achilles tendon in rats. Olcay E; Beytemur O; Kaleagasioglu F; Gulmez T; Mutlu Z; Olgac V J Toxicol Sci; 2011 Jun; 36(3):339-45. PubMed ID: 21628961 [TBL] [Abstract][Full Text] [Related]
5. Effects of fluoroquinolones on cultured articular chondrocytes flow cytometric analysis of free radical production. Thuong-Guyot M; Domarle O; Pocidalo JJ; Hayem G J Pharmacol Exp Ther; 1994 Dec; 271(3):1544-9. PubMed ID: 7996468 [TBL] [Abstract][Full Text] [Related]
6. Quantitative determination of ofloxacin, ciprofloxacin, norfloxacin and pefloxacin in serum by high pressure liquid chromatography. Groeneveld AJ; Brouwers JR Pharm Weekbl Sci; 1986 Feb; 8(1):79-84. PubMed ID: 2938073 [TBL] [Abstract][Full Text] [Related]
7. Effects of quinolones on granulocyte function in vitro. Boogaerts MA; Malbrain S; Scheers W; Verwilghen RL Infection; 1986; 14 Suppl 4():S258-62. PubMed ID: 3469158 [TBL] [Abstract][Full Text] [Related]
8. [In vitro activity of new quinolones against Mycoplasma pathogenic to humans]. Renaudin H; Quentin C; de Barbeyrac B; Bebear C Pathol Biol (Paris); 1988 May; 36(5):496-9. PubMed ID: 3136430 [TBL] [Abstract][Full Text] [Related]
9. Comparative effects of quinolones on human mononuclear leucocyte functions. Roche Y; Gougerot-Pocidalo MA; Fay M; Etienne D; Forest N; Pocidalo JJ J Antimicrob Chemother; 1987 Jun; 19(6):781-90. PubMed ID: 3497150 [TBL] [Abstract][Full Text] [Related]
10. Steady-state kinetics of the quinolone derivatives ofloxacin, enoxacin, ciprofloxacin and pefloxacin during maintenance treatment with theophylline. Wijnands WJ; Vree TB; Baars AM; van Herwaarden CL Drugs; 1987; 34 Suppl 1():159-69. PubMed ID: 3481317 [TBL] [Abstract][Full Text] [Related]
11. The influence of the 4-quinolones ciprofloxacin, pefloxacin and ofloxacin on the elimination of theophylline. Wijnands WJ; Vree TB; Baars AM; van Herwaarden CL Pharm Weekbl Sci; 1987 Dec; 9 Suppl():S72-5. PubMed ID: 3481439 [TBL] [Abstract][Full Text] [Related]
12. [Serum pharmacokinetics and in vitro antibacterial activity of pefloxacin, ofloxacin and ciprofloxacin]. Nordmann P; Jarlier V Presse Med; 1990 Sep 1-8; 19(28):1321-5. PubMed ID: 2145562 [TBL] [Abstract][Full Text] [Related]
13. [Modulation by quinolones of the in vitro proliferative response of splenic cells of the mouse and IL 1 production]. Guenounou M; Ronco E; Kodari E; Vacheron F; Momrikof V Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):785-9. PubMed ID: 3309816 [TBL] [Abstract][Full Text] [Related]
14. The comparative pharmacokinetics of five quinolones. Wise R; Lister D; McNulty CA; Griggs D; Andrews JM J Antimicrob Chemother; 1986 Nov; 18 Suppl D():71-81. PubMed ID: 3468102 [TBL] [Abstract][Full Text] [Related]
15. In vitro activity of enoxacin versus ciprofloxacin, fleroxacin, lomefloxacin, ofloxacin, pefloxacin, and rufloxacin against uropathogens. Naber KG; Well M; Hollauer K; Kirchbauer D; Witte W Chemotherapy; 1998; 44(2):77-84. PubMed ID: 9551236 [TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetics of fluoroquinolones in patients with renal insufficiency]. Iakovlev SV; Iakovlev VP; Izotova GN Antibiot Khimioter; 1995 Oct; 40(10):39-47. PubMed ID: 8660120 [No Abstract] [Full Text] [Related]
17. A comparative study of anxiogenic effects of fluoroquinolones in rats. Prabhu S; Rewari S Indian J Physiol Pharmacol; 1998 Jan; 42(1):135-8. PubMed ID: 9513807 [TBL] [Abstract][Full Text] [Related]
18. Comparative postantibacterial activities of pefloxacin, ciprofloxacin, and ofloxacin against intracellular multiplication of Legionella pneumophila serogroup 1. Rajagopalan-Levasseur P; Dournon E; Dameron G; Vilde JL; Pocidalo JJ Antimicrob Agents Chemother; 1990 Sep; 34(9):1733-8. PubMed ID: 2285286 [TBL] [Abstract][Full Text] [Related]
19. In vitro activity of pefloxacin compared with five other quinolones on nalidixic acid-resistant proteae species. Piccolomini R; Cellini L; Allocati N; Di Girolamo A; Selan L; Scazzocchio F Chemioterapia; 1988 Oct; 7(5):287-91. PubMed ID: 3224396 [TBL] [Abstract][Full Text] [Related]
20. [The in vitro activity of ofloxacin, pefloxacin and ciprofloxacin against various gram negative bacteria isolated from urinary tract infections]. Tunçkanat F; Yuluğ N Mikrobiyol Bul; 1988; 22(3):187-92. PubMed ID: 3252111 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]